Sclerotherapy of telangiectasias: a painless two-step technique.

Détails

ID Serval
serval:BIB_CB454CB71CBA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Sclerotherapy of telangiectasias: a painless two-step technique.
Périodique
Dermatologic Surgery
Auteur⸱e⸱s
Kern P.
ISSN
1524-4725 (Electronic)
ISSN-L
1076-0512
Statut éditorial
Publié
Date de publication
2012
Volume
38
Numéro
6
Pages
860-864
Langue
anglais
Notes
Publication types: Comparative Study ; Journal Article ; Randomized Controlled TrialPublication Status: ppublish
Résumé
BACKGROUND: Sclerotherapy of telangiectasias and reticular leg veins can be unpleasant and painful for some patients.
OBJECTIVE: To determine pain level with two different sclerotherapy techniques in a prospective randomized trial.
METHODS: Patients with symmetrical telangiectasias and reticular veins on both legs (C(1A) or (S)E(P)A(S)P(N1) were randomized to the standard (successive injections of chromated glycerin mixed with one-third lidocaine-epinephrine 1%) or two-step technique (first treating only reticular veins with a single injection at the base of each cluster of telangiectasias and then successively injecting all remaining telangiectasias a few minutes later. Pain was assessed using a 100-point visual analogue scale (0 = no pain, 100 = maximum pain).
RESULTS: Data from 53 consecutive patients could be evaluated. The two-step technique was significantly less painful (28.2) than the standard technique (40.6, p < .001).
CONCLUSION: The two-step technique with chromated glycerin mixed with one-third lidocaine-epinephrine 1% significantly reduces sclerotherapy pain. This may be a useful technique for patients who are particularly sensitive or afraid of sclerotherapy.
Mots-clé
Adult, Aged, Anesthetics, Local/administration & dosage, Drug Combinations, Epinephrine/administration & dosage, Female, Follow-Up Studies, Glycerol/administration & dosage, Humans, Injections, Intralesional, Leg/blood supply, Lidocaine/administration & dosage, Middle Aged, Prospective Studies, Sclerotherapy/methods, Skin/blood supply, Solvents/administration & dosage, Telangiectasis/therapy, Treatment Outcome, Vasoconstrictor Agents/administration & dosage
Pubmed
Web of science
Création de la notice
12/09/2012 18:07
Dernière modification de la notice
20/08/2019 16:46
Données d'usage